The document discusses the need for effective male contraception in India given that over 65% of the population is young and reproductive rates are high. It notes that while female contraception bears most of the burden currently, options for males are limited to condoms and vasectomies which are not always effective. It then introduces RISUG as a potential solution - an injection into the vas deferens that coats it with a polymer gel, preventing sperm from exiting for 10-15 years. RISUG is reversible, has few side effects, and could provide an easy long-term family planning method without other contraceptives needed.